S

Soleno Therapeutics
D

SLNO

76.900
USD
3.05
(4.13%)
مغلق
حجم التداول
22,600
الربح لكل سهم
-3
العائد الربحي
-
P/E
-16
حجم السوق
3,875,293,294
أصول ذات صلة
ABBV
ABBV
0.810
(0.44%)
183.260 USD
ALNY
ALNY
0.47
(0.16%)
289.82 USD
C
CRMD
0.110
(0.90%)
12.360 USD
G
GLPG
-0.130
(-0.45%)
28.730 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
T
TTNP
-0.17000
(-3.71%)
4.41000 USD
المزيد
الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.